June 16 (Reuters) - U.S. drugmaker Eli Lilly ( LLY )
said on Monday it will offer the higher dose versions of its
popular weight-loss drug Zepbound on its website LillyDirect.
The company said 12.5 milligrams and 15 mg doses of the drug
will be available for $499 per month on the website with
shipments to patients beginning in early August.